$SRNE My dream PR!! Eli Lilly, and Sorrento Therapeutics joins forces to develop multiple cocktails and run multiple clinical trials as Part of Operation Warp Speed program. Eli Lilly will acquire Sorrento Therapeutics at $ 40 per share.
  • 17
17 Likes